Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis

Matthew R. Wilson

Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Katharine L. Lewis

Sir Charles Gairdner Hospital, Perth, WA, Australia

Amy A. Kirkwood

CR UK and UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom

Kate Cwynarski

15Department of Haematology, University College London, London, United Kingdom

Chan Y. Cheah

12Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia

Tarec C. El-Galaly

Aalborg University Hospital, Aalborg, Denmark

Diego Villa

8Division of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, Canada

Kerry J. Savage

6BC Cancer, Vancouver, BC, Canada

Paola Ghione

4Memorial Sloan Kettering Cancer Center, New York, NY

Sabela Bobillo

Memorial Sloan Kettering Cancer Center, New York, NY

Karin E. Smedby

5Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Sara Harrysson

Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Marek Trneny

Magdalena Klanova

Robert Puckrin

2Arthur Child Comprehensive Cancer Centre & University of Calgary, Calgary, Canada

Christopher P. Fox

13Department of Haematology, School of Medicine, University of Nottingham, Nottingham, United Kingdom

Mark Bishton

4Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Gita Thanarajasingam

1Mayo Clinic, Hematology/Oncology, Rochester, United States

Nicole Wong Doo

5Concord Hospital, Concord Clinical School, University of Sydney, Haematology, Sydney, Australia

Greg Hapgood

10Princess Alexandra Hospital, Department of Haematology, Brisbane, Australia

Carole Soussain

1Institut Curie, Hematology, Saint Cloud, France

Sylvain Choquet

18AP-HP – Hôpital Pitié-Salpêtrière, Paris, France

Michael Dickinson

Dipti Talaulikar

19Canberra Health Services, Haematology Unit, ACT Pathology, Canberra, Australia

Sanjay De Mel

6National University Health System, Department of Haematology-Oncology, Singapore, Singapore

Gavin Preston

9Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom

Matthew Ahearne

11University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

Eliza A. Hawkes

14Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia

Elisabeth Schorb

University of Freiburg

Aline Clavert

11CHU Angers, Angers, France

Matthew Ku

Anna Guidetti

1Fondazione IRCCS Istituto nazionale dei tumori, Unit of Biostatistics for Clinical Research, Department of Data Science, Milan, Italy

Mayur Narkhede

23University of Alabama, Birmingham, AL

Teresa Calimeri

1San Raffaele Scientific Institute, Lymphoma Unit, Milan, Italy

Eric Durot

8CHU Reims, Hematology, Reims, France

Jeffrey Smith

Loïc Renaud

1Gustave Roussy Cancer Center, Hematology, Villejuif, France

Pamela McKay

10Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Toby A. Eyre

8Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom